These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9424525)

  • 1. [Severe proarrhythmias in cisapride therapy. Simple precautionary measures reduce the risk].
    Darpö B
    Lakartidningen; 1997 Nov; 94(47):4317-20. PubMed ID: 9424525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extrapyramidalism associated with the use of cisapride].
    Mariscal E; Sagalés M; Pedrol E; Pedrol E; Montull S
    Med Clin (Barc); 1998 Apr; 110(12):477-8. PubMed ID: 9611723
    [No Abstract]   [Full Text] [Related]  

  • 3. Cisapride-induced long QT interval: what is the role of ranitidine?
    Gunasekaran TS; DuBrow I
    J Pediatr; 1997 Apr; 130(4):679-80. PubMed ID: 9108876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Syncope with long QT interval in a 39 day-old infant treated with cisapride].
    Valdes L; Champel V; Olivier C; Jonville-Bera AP; Autret E
    Arch Pediatr; 1997 Jun; 4(6):535-7. PubMed ID: 9239268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long QT syndrome during high-dose cisapride.
    Bran S; Murray WA; Hirsch IB; Palmer JP
    Arch Intern Med; 1995 Apr; 155(7):765-8. PubMed ID: 7695465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychotropic drugs and the risk of arrhythmias].
    Toivonen L
    Duodecim; 2002; 118(12):1223-4. PubMed ID: 12239813
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reduction of prolonged QTc-interval related risks in treatment with neuropharmacological drugs. Recommendations for clinical practice].
    van de Kraats GB; Slob J; Tenback DE
    Tijdschr Psychiatr; 2007; 49(1):43-7. PubMed ID: 17225205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long QT syndrome under cisapride in neonates and infants].
    Lupoglazoff JM; Bedu A; Faure C; Denjoy I; Casasoprana A; Cézard JP; Aujard Y
    Arch Pediatr; 1997 Jun; 4(6):509-14. PubMed ID: 9239264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolongation of the QT interval and cardiac arrhythmias associated with cisapride: limitations of the pharmacoepidemiological studies conducted and proposals for the future.
    Layton D; Key C; Shakir SA
    Pharmacoepidemiol Drug Saf; 2003; 12(1):31-40. PubMed ID: 12616845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syncopal episodes associated with cisapride and concurrent drugs.
    Gray VS
    Ann Pharmacother; 1998 Jun; 32(6):648-51. PubMed ID: 9640482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous adverse event reports of serious ventricular arrhythmias, QT prolongation, syncope, and sudden death in patients treated with cisapride.
    Barbey JT; Lazzara R; Zipes DP
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):65-76. PubMed ID: 12075394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchospasm associated with cisapride.
    Pillans P
    BMJ; 1995 Dec; 311(7018):1472. PubMed ID: 8520336
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced arrhythmia.
    Heist EK; Ruskin JN
    Circulation; 2010 Oct; 122(14):1426-35. PubMed ID: 20921449
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisapride (Prepulsid): interactions with grapefruit and drugs.
    Morawiecka I
    CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac toxicity with cisapride.
    Farrington E
    Pediatr Nurs; 1996; 22(3):256. PubMed ID: 8717849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long QT interval.
    el-Shafei AG; Bjerregaard P
    Hosp Pract (1995); 1997 Oct; 32(10):36; author reply 39. PubMed ID: 9341632
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy in elders.
    Lilley LL; Guanci R
    Am J Nurs; 1996 Nov; 96(11):12-4. PubMed ID: 8918348
    [No Abstract]   [Full Text] [Related]  

  • 18. Cisapride-induced long QT interval.
    Lewin MB; Bryant RM; Fenrich AL; Grifka RG
    J Pediatr; 1996 Feb; 128(2):279-81. PubMed ID: 8636830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cisapride and risk of cardiac complications].
    Cataldo F
    Minerva Pediatr; 1999; 51(9-10):309-11. PubMed ID: 10783591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.
    Enger C; Cali C; Walker AM
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):477-86. PubMed ID: 12426932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.